NL-OMON38187已完成不适用
A Continuation in the Clinical Evaluation of the Abbott Vascular Everolimus-Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions - ABSORB EXTEND
Abbott Vascular International0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-) =< 2 de novo lesions can be treated, each located in a separate native epicardial vessel.
- •-) Target lesion(s) must measure <= 28 mm in length.
- •-) Target lesion(s) must be in a major artery or branch with a visually estimated stenosis of >= 50% and < 100% with a TIMI flow of >= 1.
- •-) Percutaneous interventions for lesions in a non-target vessel are allowed if done >= 30 days prior to or if planned to be done 6 months after the index procedure.
排除标准
- •-) Lesion(s) located within an arterial or saphenous vein graft or distal to a diseased (defined as vessel irregularity per angiogram and > 20% stenosed lesion by visual estimation) arterial or saphenous vein graft.
- •-) Lesion(s) involving a bifurcation with side branch vessel >= 2 mm in diameter, ostial lesion > 40% stenosed by visual estimation or side branch requiring predilatation.
- •-) Total occlusion (TIMI flow 0), prior to wire passing.
- •-) Target vessel(s) contains visible thrombus.
- •-) Another clinically significant lesion is located in the same epicardial vessel (including side branch) as the target lesion(s).
- •-) Subject has received brachytherapy in any epicardial vessel (including side branches).
研究者
相似试验
招募中
3 期
Study of implantation of Abbott Vasculars Bioresorbable Vascular Scaffold in the treatment of coronary artery diseaseCTRI/2010/091/000460Abbott Cardiovascular Systems Inc1,000
尚未招募
不适用
A clinical study to compare effectiveness of screening of retinal conditions of an eye by a software in detecting retinal diseases (diseases related to back of your eye) by processing undilated (without dilating the eyes) retinal fundus (interior surface of the eye) photographs.CTRI/2019/04/018420Carl Zeiss India Pvt Ltd
尚未招募
不适用
Clinical research and objective evaluation of the superior effect intervention of the non-drug characteristic treatment of chronic fatigue syndromechronic fatigue syndromeITMCTR2000003947Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Chinese Medicine
尚未招募
不适用
Clinical research and objective evaluation of the non-drug characteristic diagnosis and treatment system of chronic fatigue syndromechronic fatigue syndromeITMCTR2000003931Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Chinese Medicine
招募中
不适用
Clinical observational study for evaluation of the therapy outcome and the dependency of the outcome on parameters as reconstruction type and/or vitamin D level in OMS tumor patients in need of intra-oral tumor resection and reconstructioC01C02C03C04C05C06C44C40C41C07C08C09C10C11C12C13C14Malignant neoplasm of base of tongueMalignant neoplasm of other and unspecified parts of tongueMalignant neoplasm of gumMalignant neoplasm of floor of mouthMalignant neoplasm of palateMalignant neoplasm of other and unspecified parts of mouthOther malignant neoplasms of skinMalignant neoplasm of bone and articular cartilage of limbsMalignant neoplasm of bone and articular cartilage of other and unspecified sitesMalignant neoplasm of parotid glandMalignant neoplasm of other and unspecified major salivary glandsMalignant neoplasm of tonsilMalignant neoplasm of oropharynxMalignant neoplasm of nasopharynxMalignant neoplasm of piriform sinusMalignant neoplasm of hypopharynxMalignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynxDRKS00025841niversitätsklinikum derGoethe-Universität Frankfurt am MainKlinik für Mund-, Kiefer- und Plastische Gesichtschirurgie100